Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half Yearly Report

15 Dec 2010 12:00

RNS Number : 0065Y
Marechale Capital PLC
15 December 2010
 



15 December 2010

 

 

Marechale Capital plc

("Marechale" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2010.

 

Chairman's Statement

 

Marechale has had an encouraging start to the current year and I am pleased to report its return to profitability in the six months to September 2010.

 

Marechale operates as a corporate finance advisory and capital fund raising business focusing on fundraising for growth companies and funds in 3 key sectors: renewable energy, leisure and infrastructure. Marechale runs a low cost business model working with its associates on a profit share basis. Marechale has had a high success rate of executing and completing projects the Company takes on. This is due to Marechale's due diligence process prior to taking on a new client and its proprietary investor relationships.

 

In the six month period to 30 September 2010, Marechale has completed 9 transactions which have generated sufficient cash fees to achieve a small profit. Corporate finance projects include advising a major private equity house on the refinancing of a retail business and advising an international shipping business on a co-operation agreement with a Scandinavian investment group. In the leisure sector, Marechale has completed development capital projects ranging from a fundraising of £1.5m for a Southern based, managed pub business, Heartstone Inns 2 plc, from UK wealth managers and a fundraising of £5.9m for a private equity growth capital investment in an established restaurant group.

 

Marechale has also had success in the renewable energy sector forming 2 clean energy development companies which have benefitted from the UK's new Feed-in-Tariffs ("FIT"). Firstly, Marechale raised development capital for Future Biogas Ltd ("Future Biogas"), an anaerobic digestion biogas business. The development capital has funded Future Biogas's first site and the company is awaiting planning permission for future sites. Marechale has, secondly, formed and funded a new solar development company based in the South West of the UK, West Country Renewables Ltd.

 

The above projects resulted in Marechale generating commission and advisory fees, warrants and founder equity which strengthen Marechale's balance sheet and could result in significant future gains for shareholders.

 

Marechale has a healthy pipeline of engaged corporate finance projects for the second half of the year, including entering the intermediary market with the planned launch of a new renewable fund for consented FIT plants, a new Venture Capital Trust, as well as a further fund raising for Heartstone Inns 2 plc.

 

Whilst market conditions are still challenging, the growing pipeline of businesses seeking funding and an increasing appetite amongst our client base to invest in high quality investment opportunities provide us with confidence for trading next year.

 

The Board continues to consider a number of acquisitions and investments in potentially complementary fund management or financial services businesses.

 

We hope to give you further positive updates on Marechale after the March 2011 year end.

 

Shareholders can get up to date information on Marechale on the Company's website www.marechalecapital.com, and a new website will be launched shortly.

 

Mark Warde-Norbury

15 December 2010

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

 

Marechale Capital PLC

Income Statement (unaudited)

Six months ended 30th September 2010

30 Sept

30 Sept

2010

2009

Continuing operations

Revenue

299,658

-

Cost of sales

(25,343)

-

Gross profit

274,315

-

Administrative expenses

(264,935)

(315,160)

Operating profit/ (loss)

9,380

(315,160)

Investment revenues

646

1,748

Other gains and losses

-

(1,408)

Profit/ (loss) before tax

10,026

(314,820)

Corporation tax charge

-

-

Profit/ (loss) for the period on continuing operations

10,026

(314,820)

Loss for the period on discontinued operations*

 

Profit/ (Loss) for the period

 

 

 

 

Earnings per share

-

 

 

10,026

(58,353)

 

 

(373,173)

Basic and diluted

47,437,410 shares (2009:42,741,106)

0.02p

(0.87p)

* On 14th September 2009 the AIM Broking and PLUS Adviser businesses and associated assets were sold to Whim Gully Capital LLP for a consideration of £200,000.

Marechale Capital PLC

Balance Sheet (unaudited)

As at 30th September 2010

30 Sept

30 Sept

2010

2009

Non current assets

Property, plant and equipment

-

15,929

Current assets

Available for sale investments

67,707

110,614

Trading investments

-

6,089

Trade and other receivables

144,848

241,037

Cash and cash equivalents

294,156

541,153

506,711

898,893

Total assets

506,711

914,822

Current liabilities

Trade and other payables

(94,682)

(132,179)

Corporation tax

-

19,281

Total current liabilities

(94,682)

(112,898)

Net assets

412,029

801,923

Equity

Capital and reserves attributable to equity shareholders

Share capital

2,371,872

2,137,055

Share premium account

1,177,452

1,177,452

Revaluation reserves

28,324

36,773

Other reserves

(50,254)

683,591

Retained earnings

(3,115,365)

(3,232,948)

412,029

801,923

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flow Statement (unaudited)

Six months ended 30th September 2010

30 Sept

30 Sept

2010

2009

Net cash from operating activities

Operating profit/ (loss) from continuing operations

9,380

(315,160)

Depreciation

-

21,000

Operating loss from discontinued operations

 -

 (58,353)

Share based payments re discontinued operations

-

 

80,000

Operating cash flows before movements in working capital

9,380

(272,513)

Movement in working capital

(Increase)/ decrease in receivables

(81,874)

91,960

(Decrease)/ increase in payables

(23,428)

(30,963)

(105,302)

60,998

Operating cash flow

(95,922)

(211,515)

Investment activities

Interest receivable

646

1,749

Proceeds on disposal of trading investments

-

(1)

Proceeds on disposal of available for sale investments

-

-

Expenditure on tangible fixed assets

-

-

Expenditure on trading investments

(10,000)

-

Cash flow from investing activities

(9,354)

1,748

Financing

Issue of share capital

-

-

Interest payable

-

-

Cash flow from financing activities

-

-

Net increase/(decrease) in cash and cash equivalents

(105,276)

(209,767)

Cash and cash equivalents at start of period

399,432

750,921

Cash and cash equivalents at end of period

294,156

541,153

Increase/(decrease) in cash and cash equivalents

(105,276)

(209,767)

 

This financial information has been in accordance with IFRS and International Financial Reporting

Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those

parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior periods

being reported on the same basis.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FELFFBLFFFBF
Date   Source Headline
8th Jun 20267:00 amPRNFCA Approves Stanford Capital Partners Change in Control
3rd Jun 20267:00 amPRNPosting of Circular and Notice of General Meeting
10th Apr 20261:00 pmPRNWeardale Lithium Receives £700k Grant
19th Jan 202612:15 pmPRNHalf-year Report
14th Oct 20254:00 pmPRNResult of AGM
14th Oct 20257:00 amPRNSubscription, Directors' Dealings, Related Party Transaction and Issue of Equity
16th Sep 20259:30 amPRNNotice of AGM
22nd Aug 20257:00 amPRNFinal Results
13th May 20257:00 amPRNIssue of Options to PDMR
19th Mar 20257:00 amPRNMarechale Advises on the Sale of Randalls
5th Feb 20251:30 pmPRNWeardale Lithium Planning Permission Application Update
29th Jan 202511:37 amPRNShare Price Movement
19th Dec 20244:30 pmPRNHalf-year Report
15th Oct 20242:30 pmPRNResult of AGM
20th Sep 20247:00 amPRNNotice of AGM
20th Aug 20247:00 amPRNFinal Results
6th Aug 20247:00 amPRNAppointment of Director
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.